Correction: Swiss QUality of life and healthcare impact Assessment in a Real-world Erenumab treated migraine population (SQUARE study): interim results

Affiliations

• ¹ Department of Neurology and Neurorehabilitation, ZURZACH Care, Bad Zurzach, Switzerland. andreas.gantenbein@zurzachcare.ch.
• ² Kopfwehzentrum Hirslanden, Zurich, Switzerland.
• ³ Department of Neurology, Inselspital, University Hospital Bern and University of Bern, Bern, Switzerland.
• ⁴ Neurocentre, Luzerner Kantonsspital, Lucerne, Switzerland.
• ⁵ Center for Pain Medicine, Nottwil, Switzerland.
• ⁶ Department of Neurology, Spital Thun, Thun, Switzerland.
• ⁷ Department of Reproductive Endocrinology, University Hospital Zurich, Zurich, Switzerland.
• ⁸ Neurozentrum Bern, Bern, Switzerland.
• ⁹ Department of Neurology, University Hospital Zurich, Zurich, Switzerland.
• ¹⁰ Department of Clinical Neurosciences, CHUV, Lausanne, Switzerland.
• ¹¹ Private Practice, Sion, Switzerland.
• ¹² Neurocenter of Southern Switzerland, Ente Ospedaliero Cantonale (EOC), Lugano, Switzerland.
• ¹³ Faculty of Biomedical Sciences, Università Della Svizzera Italiana, Lugano, Switzerland.
• ¹⁴ Department of Neurology and Neurorehabilitation, ZURZACH Care, Bad Zurzach, Switzerland.
• ¹⁵ Novartis Pharma Schweiz AG, Rotkreuz, Switzerland.